Ncardia (Pluriomics)

Clyde Biosciences

This company provides cardiac safety and efficacy testing services for pharmaceutical and biotechnology organisations using its proprietary cell-based assay platform.

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

Oscillution

This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.

Stemnovate

This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.

Axol Bioscience

This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.

MeOmics

The company develops a precision psychiatry platform using patient-derived stem cells and AI to help drug developers accelerate psychiatric medicine discovery.

StemoniX

This deep-tech company develops human stem cell-derived organoid platforms for pharmaceutical and biotechnology customers to conduct drug discovery and toxicity screening.

Tissue Dynamics

This company develops sensor-integrated organ-on-chip platforms for pharmaceutical, nutraceutical and cosmetic customers to accelerate drug discovery and safety testing.